Qiming Venture Partners’ Post

View organization page for Qiming Venture Partners
Qiming Venture Partners

13,670 followers

We are delighted to share that Xinzeyuan, a leading platform in the minimally invasive surgical supply chain and a portfolio company of Qiming Venture Partners, has successfully completed its B+ round of financing, raising nearly RMB 100 million. Qiming Venture Partners has led in the Series B round and continued to invest in this round. The company has secured two rounds of financing within just six months, reflecting strong recognition and confidence from investment institutions. Founded in 2015, Xinzeyuan has built a robust platform centered on the full supply chain of minimally invasive medical devices. Its core business spans four key areas: rigid endoscopes, flexible endoscopes, endoscopic surgical devices, and minimally invasive surgical devices, serving a wide range of medical brands. Oscar Zhang, Partner of Qiming Venture Partners, said, "In the six months since we led Xinzeyuan's Series B round, the company has made significant strides in product development and business expansion. We have been continually impressed by Xinzeyuan's innovation and execution. We remain confident in the future of China's medical device industry and are committed to supporting exceptional companies like Xinzeyuan as they grow and make their mark on the global stage." #InnovationInHealthcare #MinimallyInvasiveSurgery #MedicalDevices #VentureCapital #MedTechLeadership #QimingPortfolio #QimingHealthcare

  • No alternative text description for this image

To view or add a comment, sign in

More Relevant Posts

Qiming Venture Partners

13,670 followers

View Profile

Explore topics